Irbesartan Teva (Irbesartan)

Irbesartan blocks the angiotensin II type 1 (AT1) receptors, preventing angiotensin II from causing blood vessels to narrow and from stimulating aldosterone release. This results in vasodilation, reduced fluid retention, and lower blood pressure, while also providing renal protective effects.

The appropriate dose of Irbesartan Teva is individualized by the prescribing healthcare professional based on the patient’s blood pressure, kidney function, and overall clinical condition. Dosage adjustments may be needed during treatment, but the exact regimen is set by the prescriber.

Irbesartan is generally not recommended during pregnancy because it can affect fetal development, particularly in the second and third trimesters. Limited data are available for breastfeeding, and the drug may pass into breast milk; therefore, a healthcare provider should be consulted before use.

To order Irbesartan Teva, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any special handling), and necessary import documentation.

Irbesartan belongs to the ARB class, which offers blood‑pressure control similar to ACE inhibitors but with a lower incidence of cough and angioedema. Unlike ACE inhibitors, ARBs do not affect bradykinin metabolism, making them better tolerated for many patients while providing comparable cardiovascular and renal benefits.

Irbesartan Teva tablets should be stored at room temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the medication out of reach of children and do not use if the packaging is damaged.

Irbesartan Teva is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing instructions provided by their prescriber and not alter the schedule without medical advice.

The most serious risks include angioedema (swelling of the face, lips, tongue, or throat), severe hyperkalemia (high potassium levels), and acute renal impairment. Patients should seek immediate medical attention if they experience swelling, difficulty breathing, sudden loss of kidney function, or marked changes in blood potassium.

Irbesartan Teva should be avoided in patients with known hypersensitivity to Irbesartan or any component of the formulation, in those with severe hepatic impairment, and in pregnant women. Caution is also advised for individuals with existing hyperkalemia or severe renal dysfunction.